Healthcare Opportunities for Food Ingredient Manufacturers

Published: October 1, 2007 | Price: $995.00 – $1,990.00

For food ingredient companies willing to enter the non-food market, there is over a billion dollars of market potential awaiting them. In addition to increasing the profitability of their traditional product lines, producers of ingredients can potentially expand their markets by moving their products or byproducts into the healthcare sector, where drug producers or manufacturers of some biomedical devices could incorporate them into their products. Kalorama Information's Healthcare Opportunities for Food Ingredient Manufacturers details the sources of ancillary revenue that...

Prescribing Pharmacists: A Decision Maker Emerges

Published: October 1, 2007 | Price: $995.00 – $5,000.00

In five years, Kalorama Information believes that given the role of pharmacists currently and the demands of the US healthcare system, pharmacists will be prescribing in at least six states in five years, creating a trend that will spread to many other states in following years. The state of Florida allows some independing prescribing off an approved list, and many states allow prescription choice from a physicians diagnosis. The cost of copays and the time spent on doctor visits will...

Cell-Based Diagnostics – Technology, Applications, and Markets, 2nd Edition

Published: November 1, 2007 | Price: $1,995.00 – $3,990.00

No longer is cell-based diagnostics simply a histological study of biopsied and surgical tissues. Combinations of tests and technologies are coming together to create a new map of cell diagnostics. Image cytometry, microfluidics, microarrays, and biosensors, special immunohistochemical and in situ hybridization probes are creating new approaches to cell and tissue observation, diagnostics and pharmacogenomics. This report covers assay systems that use cells as the basic source material. Sources of the cells to be studied include peripheral blood, cord blood,...

Offshoring Clinical Trials (The Market for Clinical Trials in India, China, Mexico, Brazil, Russia and Israel.)

Published: November 1, 2007 | Price: $1,500.00 – $7,000.00

Offshoring of clinical trials is increasing as companies in the U.S. are finding challenges in clinical trial research ranging from cost, patient recruitment, patient compliance during participation, qualified professionals, new clinical trial patients, and other problems. This provides an opportunity for BRIC countries and other developing regions to grab a piece of the clinical trial market. Countries such as India and China have a vast population who are interested in taking part in clinical trial research, and these regions can...

Contract Manufacturing in Medical Devices (Raw Materials, Electronics and Finished Products Markets)

Published: November 1, 2007 | Price: $3,800.00 – $13,990.00

The trend of medical device outsourcing, or contract manufacturing is increasing. This Kalorama Information report takes an exhaustive look at the total market of OEMs outsourcing device manufacture to CMs. This publication represents the total OEM contract manufacturing market - it is the combination of three volumes in Kalorama Information's OEM Contract Manufacturing in Medical Devices Series. (The publication is combined for PDF delivery and hard copy delivery would come in three seperate volumes) For electronic delivery, a special overview...

Worldwide Market for Rheumatoid Arthritis and Lupus Treatments ( Autoimmune Disease Markets )

Published: January 1, 2008 | Price: $995.00 – $7,000.00

Rheumatoid arthritis and lupus belong to a number of autoimmune diseases affecting the musculoskeletal system, multisystemic tissue, and connective tissues. Although a range of autoimmune conditions carry a low prevalence, combined these diseases amount to a growing medical and economic burden. Additionally, autoimmune diseases are accounting for a growing cause of disability in the United States, Europe and worldwide. Kalorama's Worldwide Market for Rheumatoid Arthritis and Lupus Treatments (Autoimmune Disease Markets) is the most comprehensive look at the markets for...

Organ Transplant Immunosuppressive Markets

Published: January 1, 2008 | Price: $995.00 – $1,990.00

Improved surgical techniques and organ preservation, understanding of immunologic barriers, and the development of newer and more potent immunosuppressives have combined to improve survival of transplant patients and grafts. Rejection remains the major barrier to long-term graft survival in patients, organ transplantation therapy is highly dependent on the success of immunosuppressants to suppress the recipient’s immune responses to the foreign organ. Most transplant patients require lifelong immunosuppressive therapy to prevent rejection, except when human leukocyte antigen (HLA)-identical transplants are used....